Hjem › Steatotisk leversykdom › Ohio › Dayton
Kliniske studier for Steatotisk leversykdom i Dayton, OH
8 studier for Steatotisk leversykdom søker deltakere på steder i og rundt Dayton (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekruttererFase 3
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Dayton
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekruttererFase 3
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Dayton
- 89bio Clinical Study Site, Springboro · 14 mi unna
A Study to Investigate Safety and Efficacy of Efimosfermin Compared With Placebo in Adult Participants With Compensated Cirrhosis Due to Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 3
- GSK Investigational Site, Springboro · 14 mi unna
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RekruttererFase 3
- Dayton Gastroenterology - Beavercreek, Beavercreek · 8 mi unna
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekruttererFase 3
- Akero Clinical Study Site, Springboro · 14 mi unna
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, Springboro · 14 mi unna
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 2
- Digestive Specialists, Dayton
- DSI Research, Springboro · 14 mi unna
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, Springboro · 14 mi unna
Steatotisk leversykdom-studier i andre byer
- San Antonio, TX17 studier
- New York City, NY16 studier
- Miami, FL16 studier
- San Diego, CA14 studier
- Austin, TX13 studier
- Houston, TX13 studier
- Richmond, VA12 studier
- Tucson, AZ10 studier
- Chandler, AZ10 studier
- Hialeah, FL9 studier
- Dallas, TX9 studier
- Orlando, FL9 studier
Andre studier i Dayton
- Lungekreft14 studier
- Ikke-småcellet lungekreft13 studier
- Eggstokkreft9 studier
- Hjertesvikt8 studier
- Melanom7 studier
- Kreft (alle typer)7 studier
- Endometriekreft7 studier
- Brystkreft7 studier
- Prostatakreft7 studier
- Fedme7 studier
- Overvekt6 studier
- Ulcerøs kolitt6 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.